Skip to content

ACUVUE® OASYS MAX 1-day dispensing study

ACUVUE® OASYS MAX 1-day multifocal for astigmatism dispensing study

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN17278168
Enrollment
45
Registered
2026-07-15
Start date
2026-07-17
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Presbyopia & Astigmatism Eye Diseases

Interventions

The participants will attend the clinic for two study visits : At the first visit the participant will be fitted with the study contact lenses. A set of visual measurements and questionnaires will be

Sponsors

CooperVision International Limited
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age 40 years or greater 2. Have read and understood the participant Information Sheet 3. Have read, signed and dated the Informe Consent 4. Best corrected visual acuity of at least 20/25 in each eye 5. Have normal eyes with the exception of the need for visual correction 6. Current soft contact lenses wearer 7. Spectacle refraction: 7.1 Distance Sphere: -6.00 D to -0.50 D 7.2 Astigmatism (Cylinder): -0.75 D to -1.75 D 7.3 Axis: 10°, 20°, 30°, 70°, 80°, 90°, 100°, 110°, 150°, 160°, 170°, 180° 7.4 Near Addition: +0.75 D to +2.50 D 8. Be willing and able to adhere to the instructions set in the clinical protocol and maintain the appointment schedule

Exclusion criteria

Exclusion criteria: 1. Ocular anterior segment infection, inflammation, abnormality, or active disease that would contraindicate contact lens wear 2. Newly prescribed (within the past 30 days) use of some systemic medications (such as antihistamines, decongestants, diuretics, muscle relaxants, tranquilizers, stimulants, anti-depressants, anti-psychotics, oral contraceptives) or new prescription eyedrops which is not rewetting/lubricating eyedrops for which contact lens wear could be contraindicated as determined by the investigatorMonocular participants (only one eye with functional vision) or participants fit with only one lens 3. Monocular participants (only one eye with functional vision) or participants fit with only one lens 4. Any moderate or severe ocular condition observed during the slit-lamp examination at the enrolment visit 5. History of herpetic keratitis, ocular surgery or irregular cornea 6. Known pregnancy or lactation during the study period 7. Enrolment of the investigator or his/her staff, family members of the investigator, family members of the investigator’s staff, or individuals living in the households of these individuals

Design outcomes

Primary

MeasureTime frame
Overall vision satisfaction at the completion of the wearing period measured using a 100-point Visual Analogue Scale (VAS) at visit 2

Countries

England, United Kingdom

Contacts

Public ContactDeborah Moore
dmoore@otg.co.uk+44 02072224224

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Aug 10, 2026